The activation and physiological functions of the proprotein convertases

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 6-7, 2008, Pages 1111-1125

  Seidah, Nabil G ^a   Mayer, Gaetan ^a   Zaid, Ahmed ^a   Rousselet, Estelle ^a   Nassoury, Nasha ^a   Poirier, Steve ^a   Essalmani, Rachid ^a   Prat, Annik ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Bone morphogenic factors; Cell surface substrate cleavage; Endosomes lysosomes; Growth differentiating factor 11; HDL cholesterol; Heparan sulfate proteoglycans; LDL cholesterol; LDLR; PC5 6; PCSK9; Proprotein convertases; TGF

Indexed keywords

AMINO ACID; BONE MORPHOGENETIC PROTEIN; ENZYME PRECURSOR; FURIN; GROWTH DIFFERENTIATING FACTOR 11; GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEOHEPARAN SULFATE; SERINE PROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

CATALYSIS; CELL MIGRATION; CELL SURFACE; CONGENITAL MALFORMATION; ENDOSOME; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME SPECIFICITY; HUMAN; KNOCKOUT GENE; LYSOSOME; NONHUMAN; PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SECRETORY GRANULE; STILLBIRTH; TRANS GOLGI NETWORK;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CONSENSUS SEQUENCE; ENZYME ACTIVATION; HUMANS; MOLECULAR SEQUENCE DATA; PROPROTEIN CONVERTASES; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY;

MAMMALIA; MUS;

EID: 43049141452     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.01.030     Document Type: Review

References (111)

1. Abboud S., Karhunen P.J., Lutjohann D., Goebeler S., Luoto T., Friedrichs S., et al. Proprotein convertase subtilisin/kexin Type 9 (PCSK9) gene is a risk factor of large-vessel atherosclerosis stroke. PLoS. ONE. 2 (2007) e1043
2. Anderson E.D., Molloy S.S., Jean F., Fei H., Shimamura S., and Thomas G. The ordered and compartment-specific autoproteolytic removal of the furin intramolecular chaperone is required for enzyme activation. J Biol. Chem. 277 (2002) 12879-12890
3. Anderson E.D., VanSlyke J.K., Thulin C.D., Jean F., and Thomas G. Activation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage. EMBO J. 16 (1997) 1508-1518
4. Bassi D.E., Fu J., Lopez D.C., and Klein-Szanto A.J. Proprotein convertases: "master switches" in the regulation of tumor growth and progression. Mol. Carcinogen. 44 (2005) 151-161
5. Ben Haim N., Lu C., Guzman-Ayala M., Pescatore L., Mesnard D., Bischofberger M., et al. The nodal precursor acting via activin receptors induces mesoderm by maintaining a source of its convertases and BMP4. Dev. Cell 11 (2006) 313-323
6. Benjannet S., Rhainds D., Essalmani R., Mayne J., Wickham L., Jin W., et al. NARC-1/PCSK9 and its natural mutants: Zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J. Biol. Chem. 279 (2004) 48865-48875
7. Benjannet S., Rhainds D., Hamelin J., Nassoury N., and Seidah N.G. The proprotein convertase PCSK9 is inactivated by furin and/or PC5/6A: Functional consequences of natural mutations and post-translational modifications. J Biol. Chem. 281 (2006) 30561-30572
8. Benjannet S., Rondeau N., Paquet L., Boudreault A., Lazure C., Chretien M., et al. Comparative biosynthesis, covalent post-translational modifications and efficiency of prosegment cleavage of the prohormone convertases PC1 and PC2: glycosylation, sulphation and identification of the intracellular site of prosegment cleavage of PC1 and PC2. Biochem. J. 294 Pt 3 (1993) 735-743
9. Bennett K.L., Jackson D.G., Simon J.C., Tanczos E., Peach R., Modrell B., et al. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol. 128 (1995) 687-698
10. Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., et al. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68 (1999) 729-777
11. Bishop J.R., Schuksz M., and Esko J.D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446 (2007) 1030-1037
12. Cameron J., Holla O.L., Ranheim T., Kulseth M.A., Berge K.E., and Leren T.P. Effect of mutations in the PCSK9 gene on the cell surface LDL receptors. Hum. Mol. Genet. 15 (2006) 1551-1558
13. Constam D.B., Calfon M., and Robertson E.J. SPC4, SPC6, and the novel protease SPC7 are coexpressed with bone morphogenetic proteins at distinct sites during embryogenesis. J. Cell Biol. 134 (1996) 181-191
14. Constam D.B., and Robertson E.J. SPC4/PACE4 regulates a TGFbeta signaling network during axis formation. Genes Dev. 14 (2000) 1146-1155
15. Creemers J.W., Vey M., Schafer W., Ayoubi T.A., Roebroek A.J., Klenk H.D., et al. Endoproteolytic cleavage of its propeptide is a prerequisite for efficient transport of furin out of the endoplasmic reticulum. J. Biol. Chem. 270 (1995) 2695-2702
16. Cui Y., Hackenmiller R., Berg L., Jean F., Nakayama T., Thomas G., et al. The activity and signaling range of mature BMP-4 is regulated by sequential cleavage at two sites within the prodomain of the precursor. Genes Dev. 15 (2001) 2797-2802
17. Cui Y., Jean F., Thomas G., and Christian J.L. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development. EMBO J. 17 (1998) 4735-4743
18. Cunningham D., Danley D.E., Geoghegan K.F., Griffor M.C., Hawkins J.L., Subashi T.A., et al. Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia. Nat. Struct. Mol. Biol. 14 (2007) 413-419
19. De Bie I., Marcinkiewicz M., Malide D., Lazure C., Nakayama K., Bendayan M., et al. The isoforms of proprotein convertase PC5 are sorted to different subcellular compartments. J. Cell Biol. 135 (1996) 1261-1275
20. Dietschy J.M., Turley S.D., and Spady D.K. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res. 34 (1993) 1637-1659
21. Dontu G., Liu S., and Wicha M.S. Stem cells in mammary development and carcinogenesis: implications for prevention and treatment. Stem Cell Rev. 1 (2005) 207-213
22. Elagoz A., Benjannet S., Mammarbassi A., Wickham L., and Seidah N.G. Biosynthesis and cellular trafficking of the convertase SKI-1/S1P: ectodomain shedding requires SKI-1 activity. J. Biol. Chem. 277 (2002) 11265-11275
23. Espenshade P.J., Cheng D., Goldstein J.L., and Brown M.S. Autocatalytic processing of site-1 protease removes propeptide and permits cleavage of sterol regulatory element-binding proteins. J. Biol. Chem. 274 (1999) 22795-22804
24. Esquela A.F., and Lee S.J. Regulation of metanephric kidney development by growth/differentiation factor 11. Dev. Biol. 257 (2003) 356-370
25. Essalmani R., Hamelin J., Marcinkiewicz J., Chamberland A., Mbikay M., Chretien M., et al. Deletion of the gene encoding proprotein convertase 5/6 causes early embryonic lethality in the mouse. Mol. Cell Biol. 26 (2006) 354-361
26. Feliciangeli S.F., Thomas L., Scott G.K., Subbian E., Hung C.H., Molloy S.S., et al. Identification of a pH sensor in the furin propeptide that regulates enzyme activation. J. Biol. Chem. 281 (2006) 16108-16116
27. Fernandez-Catalan C., Bode W., Huber R., Turk D., Calvete J.J., Lichte A., et al. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO J. 17 (1998) 5238-5248
28. Garten W., and Klenk H.D. Understanding influenza virus pathogenicity. Trends Microbiol. 7 (1999) 99-100
29. Gauster M., Hrzenjak A., Schick K., and Frank S. Endothelial lipase is inactivated upon cleavage by the members of the proprotein convertase family. J. Lipid Res. 46 (2005) 977-987
30. Ge G., Hopkins D.R., Ho W.B., and Greenspan D.S. GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells. Mol. Cell Biol. 25 (2005) 5846-5858
31. Goldman D.C., Hackenmiller R., Nakayama T., Sopory S., Wong C., Kulessa H., et al. Mutation of an upstream cleavage site in the BMP4 prodomain leads to tissue-specific loss of activity. Development 133 (2006) 1933-1942
32. Gotte M., and Yip G.W. Heparanase, hyaluronan, and CD44 in cancers: A breast carcinoma perspective. Cancer Res. 66 (2006) 10233-10237
33. Granes F., Urena J.M., Rocamora N., and Vilaro S. Ezrin links syndecan-2 to the cytoskeleton. J. Cell Sci. 113 Pt 7 (2000) 1267-1276
34. Hacker U., Nybakken K., and Perrimon N. Heparan sulphate proteoglycans: the sweet side of development. Nat. Rev. Mol. Cell Biol. 6 (2005) 530-541
35. Henrich S., Cameron A., Bourenkov G.P., Kiefersauer R., Huber R., Lindberg I., et al. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. Nat. Struct. Biol. 10 (2003) 520-526
36. Henrich S., Lindberg I., Bode W., and Than M.E. Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity. J. Mol. Biol. 345 (2005) 211-227
37. Holst C.R., Bou-Reslan H., Gore B.B., Wong K., Grant D., Chalasani S., et al. Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival. PLoS ONE. 2 (2007) e575
38. Hooper A.J., Marais A.D., Tanyanyiwa D.M., and Burnett J.R. The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population. Atherosclerosis 193 (2007) 445-448
39. Horton J.D., Cohen J.C., and Hobbs H.H. Molecular biology of PCSK9: Its role in LDL metabolism. Trends Biochem. Sci. 32 (2007) 71-77
40. Jackson D.G., Bell J.I., Dickinson R., Timans J., Shields J., and Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J. Cell Biol. 128 (1995) 673-685
41. Jin W., Fuki I.V., Seidah N.G., Benjannet S., Glick J.M., and Rader D.J. Proprotein convertases are responsible for proteolysis and inactivation of endothelial lipase. J. Biol. Chem. 280 (2005) 36551-36559
42. Jin W., Wang X., Millar J.S., Quertermous T., Rothblat G.H., Glick J.M., et al. Hepatic proprotein convertases modulate HDL metabolism. Cell Metab. 6 (2007) 129-136
43. Kalus I., Schnegelsberg B., Seidah N.G., Kleene R., and Schachner M. The proprotein convertase PC5A and a metalloprotease are involved in the proteolytic processing of the neural adhesion molecule L1. J. Biol. Chem. 278 (2003) 10381-10388
44. Khatib A.M., Bassi D., Siegfried G., Klein-Szanto A.J., and Ouafik L. Endo/exo-proteolysis in neoplastic progression and metastasis. J. Mol. Med. 83 (2005) 856-864
45. Khatib A.M., Siegfried G., Chretien M., Metrakos P., and Seidah N.G. Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy. Am. J. Pathol. 160 (2002) 1921-1935
46. Kramer K.L., and Yost H.J. Heparan sulfate core proteins in cell-cell signaling. Annu. Rev. Genet. 37 (2003) 461-484
47. Lagace T.A., Curtis D.E., Garuti R., McNutt M.C., Park S.W., Prather H.B., et al. Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice. J. Clin. Invest. 116 (2006) 2995-3005
48. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., et al. Identification of pancreatic cancer stem cells. Cancer Res. 67 (2007) 1030-1037
49. Lidholt K., Weinke J.L., Kiser C.S., Lugemwa F.N., Bame K.J., Cheifetz S., et al. A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 2267-2271
50. Lopez-Otin C., and Overall C.M. Protease degradomics: a new challenge for proteomics. Nat. Rev. Mol. Cell Biol. 3 (2002) 509-519
51. Lusson J., Vieau D., Hamelin J., Day R., Chretien M., and Seidah N.G. cDNA structure of the mouse and rat subtilisin/kexin-like PC5: a candidate proprotein convertase expressed in endocrine and nonendocrine cells. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6691-6695
52. Maxwell K.N., and Breslow J.L. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 7100-7105
53. Mayer G., Boileau G., and Bendayan M. Furin interacts with proMT1-MMP and integrin alphaV at specialized domains of renal cell plasma membrane. J. Cell Sci. 116 (2003) 1763-1773
54. Mayer G., Boileau G., and Bendayan M. Sorting of furin in polarized epithelial and endothelial cells: expression beyond the Golgi apparatus. J. Histochem. Cytochem. 52 (2004) 567-580
55. Mayer G., Boileau G., and Bendayan M. The proprotein convertase furin colocalizes with caveolin-1 in the Golgi apparatus and endosomes of hepatocytes. Cell Tissue Res. 316 (2004) 55-63
56. Mayer G., Hamelin J., Asselin M.-C., Pasquato A., Marcinkiewicz E., Tang M., et al. The regulated cell-surface zymogen activation of the proprotein convertase PC5A directs the processing of its secretory substrates. J. Biol Chem. 283 4 (2008) 2373-2384
57. Mayne J., Raymond A., Chaplin A., Cousins M., Kaefer N., Gyamera-Acheampong C., et al. Plasma PCSK9 levels correlate with cholesterol in men but not in women. Biochem. Biophys. Res. Commun. 361 (2007) 451-456
58. McNutt M.C., Lagace T.A., and Horton J.D. Catalytic activity is not required for secreted PCSK9 to reduce low density lipoprotein receptors in HepG2 cells. J. Biol. Chem. 282 (2007) 20799-20803
59. McPherron A.C., Lawler A.M., and Lee S.J. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat. Genet. 22 (1999) 260-264
60. Mesnard D., Guzman-Ayala M., and Constam D.B. Nodal specifies embryonic visceral endoderm and sustains pluripotent cells in the epiblast before overt axial patterning. Development 133 (2006) 2497-2505
61. Morimoto-Tomita M., Uchimura K., Bistrup A., Lum D.H., Egeblad M., Boudreau N., et al. Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer. Neoplasia 7 (2005) 1001-1010
62. Morimoto-Tomita M., Uchimura K., Werb Z., Hemmerich S., and Rosen S.D. Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J. Biol. Chem. 277 (2002) 49175-49185
63. Munchar M.J., Sharifah N.A., Jamal R., and Looi L.M. CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumours. Pathology 35 (2003) 125-129
64. Nakagawa T., Hosaka M., Torii S., Watanabe T., Murakami K., and Nakayama K. Identification and functional expression of a new member of the mammalian Kex2-like processing endoprotease family: Its striking structural similarity to PACE4. J. Biochem. (Tokyo) 113 (1993) 132-135
65. Nakagawa T., Murakami K., and Nakayama K. Identification of an isoform with an extremely large Cys-rich region of PC6, a Kex2-like processing endoprotease. FEBS Lett. 327 (1993) 165-171
66. Nassoury N., Blasiole D.A., Tebon O.A., Benjannet S., Hamelin J., Poupon V., et al. The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR. Traffic 8 (2007) 718-732
67. Nour N., Mayer G., Mort J.S., Salvas A., Mbikay M., Morrison C.J., et al. The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases. Mol. Biol. Cell 16 (2005) 5215-5226
68. Park S.W., Moon Y.A., and Horton J.D. Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. J. Biol. Chem. 279 (2004) 50630-50638
69. Pasquato A., Pullikotil P., Asselin M.C., Vacatello M., Paolillo L., Ghezzo F., et al. The proprotein convertase SKI-1/S1P: in vitro analysis of lassa virus glycoprotein-derived substrates and ex vivo validation of irreversible peptide inhibitors. J. Biol. Chem. 281 (2006) 23471-23481
70. Peinado J.R., Kacprzak M.M., Leppla S.H., and Lindberg I. Cross-inhibition between furin and lethal factor inhibitors. Biochem. Biophys. Res. Commun. 321 (2004) 601-605
71. Poirier S., Mayer G., Benjannet S., Bergeron E., Marcinkiewicz J., Nassoury N., et al. The Proprotein convertase Pcsk9 induces the degradation of LDLR and its closest family members VLDLR And ApoER2. J. Biol. Chem. 283 4 (2008) 2363-2372
72. Poirier S., Prat A., Marcinkiewicz E., Paquin J., Chitramuthu B.P., Baranowski D., et al. Implication of the proprotein convertase NARC-1/PCSK9 in the development of the nervous system. J. Neurochem. 98 (2006) 838-850
73. Pullikotil P., Benjannet S., Mayne J., and Seidah N.G. The proprotein convertase SKI-1/S1P: alternate translation and subcellular localization. J. Biol. Chem. 282 (2007) 27402-27413
74. Qian Y.W., Schmidt R.J., Zhang Y., Chu S., Lin A., Wang H., et al. Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis. J. Lipid Res. 48 (2007) 1488-1498
75. Rancourt S.L., and Rancourt D.E. Murine subtilisin-like proteinase SPC6 is expressed during embryonic implantation, somitogenesis, and skeletal formation. Dev. Genet. 21 (1997) 75-81
76. Rashid S., Curtis D.E., Garuti R., Anderson N.N., Bashmakov Y., Ho Y.K., et al. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 5374-5379
77. Roebroek A.J., Schalken J.A., Bussemakers M.J., van Heerikhuizen H., Onnekink C., Debruyne F.M., et al. Characterization of human c-fes/fps reveals a new transcription unit (fur) in the immediately upstream region of the proto-oncogene. Mol. Biol. Rep. 11 (1986) 117-125
78. Roebroek A.J., Taylor N.A., Louagie E., Pauli I., Smeijers L., Snellinx A., et al. Limited redundancy of the proprotein convertase furin in mouse liver. J. Biol. Chem. 279 (2004) 53442-53450
79. Roebroek A.J., Umans L., Pauli I.G., Robertson E.J., van Leuven F., Van de Ven W.J., et al. Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase Furin. Development 125 (1998) 4863-4876
80. Sakai J., Rawson R.B., Espenshade P.J., Cheng D., Seegmiller A.C., Goldstein J.L., et al. Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells. Mol. Cell 2 (1998) 505-514
81. Scamuffa N., Calvo F., Chretien M., Seidah N.G., and Khatib A.M. Proprotein convertases: Lessons from knockouts. FASEB J. 20 (2006) 1954-1963
82. Scamuffa N., Siegfried G., Bontemps Y., Ma L., Basak A., Cherel G., et al. Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells. J. Clin. Invest. 118 (2008) 352-363
83. Scott G.K., Gu F., Crump C.M., Thomas L., Wan L., Xiang Y., et al. The phosphorylation state of an autoregulatory domain controls PACS-1-directed protein traffic. EMBO J. 22 (2003) 6234-6244
84. Seidah N.G. Unexpected similarity between the cytosolic West Nile virus NS3 and the secretory furin-like serine proteinases. Biochem. J. 393 (2006) e1-e3
85. Seidah N.G., Benjannet S., Wickham L., Marcinkiewicz J., Jasmin S.B., Stifani S., et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 928-933
86. Seidah N.G., and Chretien M. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res. 848 (1999) 45-62
87. Seidah N.G., Chretien M., and Day R. The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions. Biochimie 76 (1994) 197-209
88. Seidah N.G., Hamelin J., Mamarbachi M., Dong W., Tardos H., Mbikay M., et al. cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin- like proteinases. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3388-3393
89. Seidah N.G., Khatib A.M., and Prat A. The proprotein convertases and their implication in sterol and/or lipid metabolism. Biol. Chem. 387 (2006) 871-877
90. Seidah N.G., Mowla S.J., Hamelin J., Mamarbachi A.M., Benjannet S., Toure B.B., et al. Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 1321-1326
91. Seidah N.G., and Prat A. Precursor convertases in the secretory pathway, cytosol and extracellular milieu. Essays Biochem. 38 (2002) 79-94
92. Seidah N.G., and Prat A. The proprotein convertases are potential targets in the treatment of dyslipidemia. J. Mol. Med. 85 (2007) 685-696
93. Sopory S., Nelsen S.M., Degnin C., Wong C., and Christian J.L. Regulation of bone morphogenetic protein-4 activity by sequence elements within the prodomain. J. Biol. Chem. 281 (2006) 34021-34031
94. Stawowy P., and Fleck E. Proprotein convertases furin and PC5: targeting atherosclerosis and restenosis at multiple levels. J Mol. Med. 83 (2005) 865-875
95. Tallquist M.D., and Soriano P. Epiblast-restricted Cre expression in MORE mice: A tool to distinguish embryonic vs. extra-embryonic gene function. Genesis 26 (2000) 113-115
96. Tang M., Mikhailik A., Pauli I., Giudice L.C., Fazelabas A.T., Tulac S., et al. Decidual differentiation of stromal cells promotes proprotein convertase 5/6 expression and lefty processing. Endocrinology 146 (2005) 5313-5320
97. Tang X.X., Robinson M.E., Riceberg J.S., Kim D.Y., Kung B., Titus T.B., et al. Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma. Clin. Cancer Res. 10 (2004) 5837-5844
98. Taylor N.A., Van de Ven W.J., and Creemers J.W. Curbing activation: Proprotein convertases in homeostasis and pathology. FASEB J. 17 (2003) 1215-1227
99. Thomas G. Furin at the cutting edge: From protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell Biol. 3 (2002) 753-766
100. Timar J., and Paterson H. Localization and production of proteoglycans by HT1080 cell lines with altered N-ras expression. Cancer Lett. 53 (1990) 145-150
101. Turnbull J., Powell A., and Guimond S. Heparan sulfate: Decoding a dynamic multifunctional cell regulator. Trends Cell Biol. 11 (2001) 75-82
102. Van de Loo J.W., Creemers J.W., Bright N.A., Young B.D., Roebroek A.J., and Van de Ven W.J. Biosynthesis, distinct post-translational modifications, and functional characterization of lymphoma proprotein convertase. J. Biol. Chem. 272 (1997) 27116-27123
103. Veinot J.P., Prichett-Pejic W., Picard P., Parks W., Schwartz R., Seidah N.G., et al. Implications of proprotein Convertase 5 (PC5) in the arterial restenotic process in a porcine model. Cardiovasc. Pathol. 13 (2004) 241-250
104. Villeneuve P., Feliciangeli S., Croissandeau G., Seidah N.G., Mbikay M., Kitabgi P., et al. Altered processing of the neurotensin/neuromedin N precursor in PC2 knock down mice: A biochemical and immunohistochemical study. J. Neurochem. (2002) 783-793
105. Wolfman N.M., McPherron A.C., Pappano W.N., Davies M.V., Song K., Tomkinson K.N., et al. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 15842-15846
106. Wouters S., Decroly E., Vandenbranden M., Shober D., Fuchs R., Morel V., et al. Occurrence of an HIV-1 gp160 endoproteolytic activity in low-density vesicles and evidence for a distinct density distribution from endogenously expressed furin and PC7/LPC convertases. FEBS Lett. 456 (1999) 97-102
107. Xiang Y., Molloy S.S., Thomas L., and Thomas G. The PC6B cytoplasmic domain contains two acidic clusters that direct sorting to distinct trans-Golgi network/endosomal compartments. Mol. Biol. Cell 11 (2000) 1257-1273
108. Zhang D.W., Lagace T.A., Garuti R., Zhao Z., McDonald M., Horton J.D., et al. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat a of low density lipoprotein receptor decreases receptor recycling and increases degradation. J. Biol. Chem. 282 (2007) 18602-18612
109. Zhao Z., Tuakli-Wosornu Y., Lagace T.A., Kinch L., Grishin N.V., Horton J.D., et al. Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. Am. J Hum. Genet. 79 (2006) 514-523
110. Zheng M., Seidah N.G., and Pintar J.E. The developmental expression in the rat CNS and peripheral tissues of proteases PC5 and PACE4 mRNAs: comparison with other proprotein processing enzymes. Dev. Biol. 181 (1997) 268-283
111. Zheng M., Streck R.D., Scott R.E., Seidah N.G., and Pintar J.E. The developmental expression in rat of proteases furin, PC1, PC2, and carboxypeptidase E: implications for early maturation of proteolytic processing capacity. J. Neurosci. 14 (1994) 4656-4673